<DOC>
	<DOCNO>NCT00129831</DOCNO>
	<brief_summary>The purpose study determine safety tolerability single dos QAB149 3000 µg deliver via single-dose , dry powder inhaler patient mild moderate COPD .</brief_summary>
	<brief_title>Study Assess Safety Tolerability Incremental Doses QAB149 Adults With Mild-to-moderate Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Male and/or female patient mild moderate stable COPD , diagnose accord Global Initiative Chronic Obstructive Lung Disease ( GOLD ) guideline ; 4075 year age Prebronchodilator baseline force expiratory volume 1 second ( FEV1 ) 3080 % Quanjer predict normal value ( Quanjer et al . 1993 ) least 0.75 L FEV1/forced vital capacity ( FVC ) &lt; 70 % predict [ GOLD guideline ] . Previous smoker ( &gt; 10 packyears ) . Ten pack year define : 20 cigarette day 10 year ; 10 cigarette day 20 year ; 40 cigarette day 5 year . Current smoker , &gt; 10 pack year history , include certain condition . Vital sign ( 3 minute rest measure supine position ) within follow range : oral body temperature 35.037.5 °C ; systolic blood pressure , 100170 mm Hg ; diastolic blood pressure , 50100 mm Hg ; pulse rate , 50 90 beat per minute ( bpm ) . Patients must weigh minimum 50 kg participate study . Able provide write informed consent prior study participation . Able communicate well investigator comply requirement study . Pregnant woman nurse mother . Patients QTc interval 0.43 second male 0.45 second female screen visit . If pretreatment value Day 1 treatment period exceed 0.45 0.47 second male female respectively visit may reschedule . Patients history prolong QTc interval , family history prolong QT syndrome . Predominant diagnosis asthma . ( Patients must present without evidence active asthma . ) Patients hospitalized emergency treatment acute COPD exacerbation one month prior screen . Patients respiratory tract infection within one month prior screen . Patients concomitant pulmonary disease , include history cancer Other exclusion criterion apply .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>COPD , indacaterol , PK</keyword>
</DOC>